The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to ...

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute ...

In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...

In vivo influenza protection was achieved at a significantly lower antibody dose with intranasal compared to systemic ...

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis (MS) and the other detailing the ...